Skip to search boxSkip to navigationSkip to main content

Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa

  • Gertrudis Horna
    ,
  • María López
    ,
  • Humberto Guerra
    ,
  • Yolanda Saénz
    ,
  • Joaquim Ruiz(corresponding author)
*Corresponding author for this work
  • Universitat de Barcelona
    ,
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
    ,
  • CIBIR
    ,
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

16463

Journal (Volume, Issue Number)

Scientific Reports (Volume 8, Issue 1)

Publication milestones

  • Published - 01/12/2018

Publication status

Published - 01/12/2018

Publication IDs

  • Scopus: 85056140109
  • PubMed: 30405166

Abstract

MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-OprM expression. Therefore, this study was aimed to determine the interplay between MexAB-OprM and MexEF-OprN in 90 out of 190 P. aeruginosa clinical isolates with an efflux pump overexpression phenotype. Regarding oprD, 33% (30/90) of isolates displayed relevant modifications (RM) defined as frameshift or premature stop, both related to carbapenem resistance. On the other hand, 33% of the isolates displayed RM in nalC, nalD or mexR, which were significantly associated with multidrug resistance (MDR), non-susceptibility to carbapenems, OprD alterations and strong biofilm production. Meanwhile, the RM in MexS were associated with presence of pigment (p = 0.004). Otherwise, when all the regulators were analysed together, the association between RM in MexAB-OprM regulators and MDR was only significant (p = 0.039) when mexS was the wild type. These data show the modulatory effect of MexEF-OprN on MexAB-OprM in a clinical population of P. aeruginosa. Further studies may contribute to design of novel molecules acting on this interplay to fight against antimicrobial resistance.

Funding Details

This work was supported by internal funds of the Barcelona Institute for Global Health, ISGlobal and Fondo de Apoyo – Facultad de Medicina – Universidad Peruana Cayetano Heredia (SIDISI 60130). GH has a personal fellowship from the Schlumberger Foundation - Faculty for The Future Program. The studies of qRT-PCR of efflux pumps were performed thanks to a short stage fellowship “Ayuda SEIMC” 2018. JR was supported by a fellowship from the I3SNS program (2012–2016), of the ISCIII (grant number: CES11/012).We thank to Dr. Maria Tomás for kindly provided the P. aeruginosa strain PA14 and Donna Pringle for idiomatic correction. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.
FundersFunding numbers
Barcelona Institute for Global Health
-
Fondo de Apoyo – Facultad de Medicina – Universidad Peruana Cayetano Heredia
SIDISI 60130
Schlumberger Foundation
-
ISCIII
CES11/012